Targeted TB Testing and Treatment of Latent TB Infection (LTBI)
- Candidates for
Treatment of Latent Tuberculosis Infection (LTBI) (PDF: 96KB/1
page)
Quick reference chart showing which patients should be treated for latent tuberculosis infection (LTBI).
- Recommended Regimens
for Treatment of Latent Tuberculosis Infection (LTBI) (PDF: 73KB/1
page)
Quick reference chart showing treatment regimens used to treat latent tuberculosis infection.
- 12-Week Regimen for Treatment of Latent TB Infection
Recommendations, eligibility criteria, and frequently asked questions for the INH-RPT treatment regimen.
- Evaluation and
Monitoring During Treatment of Latent Tuberculosis Infection (LTBI)
(PDF: 27KB/1 page)
Quick reference chart showing recommended evaluation and monitoring when treating latent tuberculosis infection (LTBI).
- TB Risk Assessment (PDF:
42KB/1 page)
Checklist for use with patients in clinics or public health settings.
- Treatment of LTBI:
Monitoring Flowsheet
Flowsheet for monitoring patients receiving treatment for LTBI.
- MDH TB Medications
Program
MDH's service for providing TB medications free of charge for persons in Minnesota who are receiving treatment for LTBI or active TB disease.
- Tuberculosis (TB): Guidelines by Topic
National guidelines and updates from the Centers for Disease Control and Prevention. Attention: Non-MDH link
- Targeted
Tuberculin Skin Testing and Treatment of Latent Tuberculosis Infection
in Children and Adolescents
National pediatric guidelines for screening and treating latent TB infection. Attention: Non-MDH link
- Tumor Necrosis Factor-Alpha (TNF-Alpha) Antagonists and the Increased Risk of Tuberculosis (PDF: 51KB/2 pages)
Two-page fact sheet from the Heartland National TB Center. Attention: Non-MDH link
- Targeted Testing and Treatment of Latent TB Infection: An Online Presentation
A 60-minute online presentation produced by the Curry International TB Center. Attention: Non-MDH link
